The authors concluded that psychotherapy seemed to have an additional value compared to pharmacotherapy alone in the treatment of depression. The conclusions appear to be supported by the evidence, but should be treated with caution given the quality of the evidence and potential for bias in the review.
Results of the review
Twenty-five studies (n=2,036, range 20 to 453, most studies had fewer than 50 patients) were included in the review. Study quality varied. Only five studies met all three criteria. Eight studies reported independent allocation. Eighteen studies reported blinding of assessors and 16 reported ITT analysis. Drop-out rates were statistically significantly lower for combined treatment compared to pharmacotherapy alone (OR 0.65, 95% CI 0.50 to 0.83, I 2 =0.62; 19 studies).
There was a small pooled effect size in favour of the combined treatment group compared to the group that received pharmacotherapy alone (ES 0.31, 95% CI 0.20 to 0.43, NNT=5.75; 25 studies). The effect size was comparable in studies that used HDRS and BDI. Sensitivity analyses did not significantly alter the results. There was no evidence of significant statistical heterogeneity or publication bias.
Subgroup analyses indicated statistically significantly lower effect sizes between studies aimed at patients with dysthymia (ES=0.00; five studies) and studies aimed at patients with major depressive disorder (ES=0.40; 20 studies) and between studies in which SSRIs were used compared to studies in which tricyclic antidepressants and other pharmacotherapies were used (p=0.004). Greater effect sizes were found in studies recruiting patients from clinical samples (ES 0.44; 18 studies) compared to studies that recruited in other ways (ES 0.08; seven studies). Further subgroup analyses in patients with major depressive disorder resulted in small effect sizes, but differences between patients recruited from clinics compared to other methods and patients who took SSRIs compared to patients who took tricyclic antidepressants were no longer statistically significant. There was evidence of statistical heterogeneity among studies that analysed data on completors only (I 2 =56.11%).
Meta-regression analysis was reported in the review.
Authors' conclusions
Psychotherapy seemed to have an additional value compared to pharmacotherapy alone in the treatment of depression.
CRD commentary
The review question and inclusion criteria were clearly stated. A number of electronic databases were searched without language restrictions. No attempts were made to locate unpublished data. Publication bias was assessed and was not found to be present. Study quality was assessed and appeared to be generally poor. The authors did not state whether each stage of the process was undertaken in duplicate, so reviewer error and bias could not be ruled out. Appropriate methods were used to combine studies and assess statistical heterogeneity. The authors acknowledged certain limitations with the included studies, such as small number of studies and small sample size, limited study quality and lack of longterm follow-up.
The authors' conclusions appeared to be supported by the evidence, but should be treated with caution given the quality of the evidence and potential for bias in the review.
